Cite

    Nezami, M. et al. (2019). Preclinical and preliminary clinical reports for successful treatment of ovarian cancer with standard treatments in combination with epigenetic modifiers in a complimentary and integrative approach. Clinical and medical reports. 2 (2), p. . [Online].